Genomind Inc. is a leading precision mental health company singularly focused on filling the innovation gap in mental health care through advanced, genetics-based digital tools and services. Our founders, each with a legacy in compassionate patient care and psychiatric innovation, have carved a path to provide a more complete picture of our mental health. While our heritage is rooted in pharmacogenetic testing, we have since grown our vision to serve a broader purpose that we hope will help to remove the stigma associated with mental health. Our mission is to deliver the most comprehensive precision mental health platform that will serve as a gateway for individuals to gain valuable insight into their own behavior and for healthcare professionals to access critical information to guide more informed decisions for mental health treatment.